A randomized controlled trial of Family Focused Grief Therapy (FFGT) commenced during palliative care and continued with the surviving relatives into bereavement explores a comprehensive model of family-centered care for hospice and palliative care services. High risk families are targeted in this intervention, which seeks to optimize family functioning and promote adaptive coping with the death of a family member, ultimately reducing the development of complicated grief preventively. In this study design conducted across 3 sites, a routine family educational session is conducted and the families are provided with a Family Carers Guideline Booklet so that the baseline is standardized. A screening procedure is used to identify families considered 'at risk' of complicated bereavement. Following recruitment, families are randomized to one of three study conditions: usual palliative care, usual palliative care plus 6 sessions of FFGT, usual palliative care plus 10 sessions of FFGT. In this manner, dose responsiveness of FFGT is explored. Study objectives are:
Aim 1 : To demonstrate the efficacy and dose responsiveness of FFGT in preventing complicated bereavement and depression compared with standard palliative care among high risk family members of patients dying from terminal cancer.
Aim 2 : To examine whether the style of family adaptation and coping mediates the impact of FFGT.
Aim 3 : To examine the costs of FFGT and standard palliative care, and to assess whether the additional costs associated with FFGT delivery are offset by reductions in community health utilization and lost work days among family members. In demonstrating the efficacy of FFGT, this study has the potential to introduce a comprehensive and yet cost effective approach to family-centered care, where families currently represent a seriously underserved population. Bereavement care will be approached preventively with a continuity of care model.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA115329-02
Application #
7115683
Study Section
Special Emphasis Panel (ZCA1-SRRB-3 (M1))
Program Officer
O'Mara, Ann M
Project Start
2005-09-01
Project End
2010-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
2
Fiscal Year
2006
Total Cost
$695,430
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Kissane, David W; Zaider, Talia I; Li, Yuelin et al. (2016) Randomized Controlled Trial of Family Therapy in Advanced Cancer Continued Into Bereavement. J Clin Oncol 34:1921-7
Masterson, Melissa P; Hurley, Karen E; Zaider, Talia et al. (2015) Toward a model of continuous care: A necessity for caregiving partners. Palliat Support Care 13:1459-67
Masterson, Melissa P; Hurley, Karen E; Zaider, Talia et al. (2015) Psychosocial Health Outcomes for Family Caregivers Following the First Year of Bereavement. Death Stud 39:573-8
Schuler, Tammy A; Zaider, Talia I; Li, Yuelin et al. (2014) Typology of perceived family functioning in an American sample of patients with advanced cancer. J Pain Symptom Manage 48:281-8
Del Gaudio, F; Hichenberg, S; Eisenberg, M et al. (2013) Latino values in the context of palliative care: illustrative cases from the Family Focused Grief Therapy trial. Am J Hosp Palliat Care 30:271-8
Masterson, Melissa P; Schuler, Tammy A; Kissane, David W (2013) Family focused grief therapy: a versatile intervention in palliative care and bereavement. Bereave Care 32:117-123
Mondia, Stephen; Hichenberg, Shira; Kerr, Erica et al. (2012) The impact of Asian American value systems on palliative care: illustrative cases from the family-focused grief therapy trial. Am J Hosp Palliat Care 29:443-8
Del Gaudio, Francesca; Zaider, Talia I; Brier, Moriah et al. (2012) Challenges in providing family-centered support to families in palliative care. Palliat Med 26:1025-33
Zaider, Talia; Kissane, David (2009) The assessment and management of family distress during palliative care. Curr Opin Support Palliat Care 3:67-71